These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2168421)

  • 1. The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor.
    Bayne ML; Applebaum J; Chicchi GG; Miller RE; Cascieri MA
    J Biol Chem; 1990 Sep; 265(26):15648-52. PubMed ID: 2168421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analogs of human insulin-like growth factor (IGF) I with altered affinity for type 2 IGF receptors.
    Cascieri MA; Chicchi GG; Applebaum J; Green BG; Hayes NS; Bayne ML
    J Biol Chem; 1989 Feb; 264(4):2199-202. PubMed ID: 2536701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type 1 IGF receptor.
    Bayne ML; Applebaum J; Underwood D; Chicchi GG; Green BG; Hayes NS; Cascieri MA
    J Biol Chem; 1989 Jul; 264(19):11004-8. PubMed ID: 2472386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity.
    Clemmons DR; Cascieri MA; Camacho-Hubner C; McCusker RH; Bayne ML
    J Biol Chem; 1990 Jul; 265(21):12210-6. PubMed ID: 1695626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutants of human insulin-like growth factor I with reduced affinity for the type 1 insulin-like growth factor receptor.
    Cascieri MA; Chicchi GG; Applebaum J; Hayes NS; Green BG; Bayne ML
    Biochemistry; 1988 May; 27(9):3229-33. PubMed ID: 2839228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analogs of human insulin-like growth factor I with reduced affinity for serum binding proteins and the type 2 insulin-like growth factor receptor.
    Bayne ML; Applebaum J; Chicchi GG; Hayes NS; Green BG; Cascieri MA
    J Biol Chem; 1988 May; 263(13):6233-9. PubMed ID: 2966152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered ligand specificity of proteolysed insulin-like growth factor binding protein-3.
    Baxter RC; Skriver L
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1267-73. PubMed ID: 7504473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations at positions 11 and 60 of insulin-like growth factor 1 reveal differences between its interactions with the type I insulin-like-growth-factor receptor and the insulin receptor.
    Hodgson DR; May FE; Westley BR
    Eur J Biochem; 1995 Oct; 233(1):299-309. PubMed ID: 7588759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromaffin cells express two types of insulin-like growth factor receptors.
    Danielsen A; Larsen E; Gammeltoft S
    Brain Res; 1990 Jun; 518(1-2):95-100. PubMed ID: 2167752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs.
    Clemmons DR; Dehoff ML; Busby WH; Bayne ML; Cascieri MA
    Endocrinology; 1992 Aug; 131(2):890-5. PubMed ID: 1379166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor II binding to the type I somatomedin receptor. Evidence for two high affinity binding sites.
    Casella SJ; Han VK; D'Ercole AJ; Svoboda ME; Van Wyk JJ
    J Biol Chem; 1986 Jul; 261(20):9268-73. PubMed ID: 3013881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of affinity-purified type I insulin-like growth factor receptor from human placenta.
    Maly P; Lüthi C
    Biochem Biophys Res Commun; 1986 Aug; 138(3):1257-62. PubMed ID: 3019338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
    Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
    Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding sites of insulin-like growth factor I (IGF I) to type I IGF receptor and to a monoclonal antibody. Mapping by chemical modification of tyrosine residues.
    Maly P; Lüthi C
    J Biol Chem; 1988 May; 263(15):7068-72. PubMed ID: 2966799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes.
    Cara JF; Nakagawa SH; Tager HS
    Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors for insulin-like growth factors and insulin on murine fetal cortical brain cells.
    Van Schravendijk CF; Hooghe-Peters EL; Van den Brande JL; Pipeleers DG
    Biochem Biophys Res Commun; 1986 Feb; 135(1):228-38. PubMed ID: 3006682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor.
    Gauguin L; Klaproth B; Sajid W; Andersen AS; McNeil KA; Forbes BE; De Meyts P
    J Biol Chem; 2008 Feb; 283(5):2604-13. PubMed ID: 18048361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin and insulin-like growth factor (somatomedin) receptors on cloned rat pituitary tumor cells.
    Rosenfeld RG; Ceda G; Cutler CW; Dollar LA; Hoffman AR
    Endocrinology; 1985 Nov; 117(5):2008-16. PubMed ID: 2995005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs).
    McCusker RH; Camacho-Hubner C; Bayne ML; Cascieri MA; Clemmons DR
    J Cell Physiol; 1990 Aug; 144(2):244-53. PubMed ID: 2166057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
    Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
    Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.